STTR in practice · NSF · Phase II
Measuring a baby’s oxygen level through the mother’s abdomen
Public award record. INSTAR Lab was not involved. This is a federal award made to another organisation. INSTAR Lab did not apply for it, take part in it or contribute to it, and nothing here says otherwise.
A medical-device company is refining a sensor that shines near-infrared light on a pregnant woman’s abdomen to estimate the baby’s blood oxygen during labour. Phase II adds device revisions and a pilot patient study with clinical researchers. The record lists the end date as March 2027, so the work is still running.
The problem
The record says better fetal monitoring could improve outcomes, reduce cost and cut unnecessary interventions during childbirth.
Partners and roles
Roles are summarised from the record’s own description. Work shares are not given unless noted.
StorX Technologies, Inc.
Small business
The awardee. It builds and revises the device prototype.
What the record does not say
- The name of the research institution. The abstract only refers to “the partner research institution” and a team of clinical researchers.
- Any result or outcome of the project.
Phase and timeline
- Starts
- April 15, 2023
- Ends
- March 31, 2027
- Length
- About 48 months
- Agency
- National Science Foundation, Directorate for Technology, Innovation, and Partnerships (TIP)
- Award number
- 2233238
- Amount
- $1,195,735. Funds obligated to date per the NSF award record (fiscal year 2023 and fiscal year 2025 instalments).
- Dates
- April 15, 2023 to March 31, 2027, as the record lists them
Outcome
The record does not state an outcome, so none is given here.
Source
Official record: NSF Award Search record 2233238(official title: STTR Phase II: Accurate Fetal Health Monitoring During Labor and Delivery). Checked October 23, 2026. Details can change after that date; the official record is the authority.
INSTAR Lab has not yet held an STTR award. This page describes how another organisation’s award is set out in public records. It does not suggest INSTAR Lab took part, or that it would be eligible for or win similar funding.